Table 1 The demographic characteristics of the patients
From: Risk factors affecting outcome of rhino-orbital-cerebral mucormycosis in COVID-19 patients
| Â | Total no. = 33 |
|---|---|
Age | |
 Mean ± SD | 54.27 ± 12.73 |
 Range | 32–82 |
Sex | |
 Male | 17 (51.5%) |
 Female | 16 (48.5%) |
Occupation | |
 Not working | 8 (24.2%) |
 Housewife | 16 (48.5%) |
 Employer | 4 (12.1%) |
 Worker | 3 (9.1%) |
 On pension | 2 (6.1%) |
Smoking | 8 (24.2%) |
Diabetes | 30 (90.9%) |
Controlled | 11 (36.7%) |
Uncontrolled | 19 (57.6%) |
Newly diagnosed | 2 (6.7%) |
DKA on admission | 8 (26.7%) |
Immunosuppressive drugs | 0 (0.0%) |
Chronic liver disease | 1 (3.0%) |
Chronic kidney disease | 1 (3.0%) |
Hematologic malignancy | 0 (0.0%) |
Prolonged antibiotic or antiviral therapy | 9 (27.3%) |
Autoimmune disease | 1 (3.0%) |
Prolonged steroid use | 29 (88%) |
Chemotherapy | 0 (0.0%) |
Thrombocytopenia | 2 (6.1%) |